Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$289K Buy
2,442
+371
+18% +$45.9K 0.01% 552
2025
Q4
$261K Sell
2,071
-1,050
-34% -$137K ﹤0.01% 557
2025
Q3
$457K Sell
3,121
-213
-6% -$32.2K 0.01% 380
2025
Q2
$520K Buy
3,334
+1,336
+67% +$212K 0.01% 342
2025
Q1
$329K Buy
1,998
+248
+14% +$41.2K 0.01% 336
2024
Q4
$285K Sell
1,750
-2
-0.1% -$358 0.01% 348
2024
Q3
$342K Buy
+1,752
New +$323K 0.01% 315
2024
Q2
Sell
-1,674
Closed -$283K 409
2024
Q1
$283K Buy
+1,674
New +$314K 0.01% 332
2023
Q4
Sell
-1,468
Closed -$255K 380
2023
Q3
$255K Buy
1,468
+63
+4% +$11.4K 0.01% 319
2023
Q2
$242K Buy
1,405
+129
+10% +$22.3K 0.01% 317
2023
Q1
$212K Buy
+1,276
New +$209K 0.01% 323
2022
Q4
Sell
-1,853
Closed -$275K 1172
2022
Q3
$275K Sell
1,853
-372
-17% -$62.2K 0.01% 274
2022
Q2
$382K Sell
2,225
-951
-30% -$164K 0.01% 249
2022
Q1
$599K Buy
3,176
+13
+0.4% +$2.57K 0.02% 216
2021
Q4
$772K Buy
3,163
+57
+2% +$12.5K 0.02% 200
2021
Q3
$603K Sell
3,106
-3
-0.1% -$605 0.02% 215
2021
Q2
$579K Buy
3,109
+208
+7% +$36.1K 0.02% 229
2021
Q1
$457K Buy
2,901
+1,908
+192% +$302K 0.02% 226
2020
Q4
$164K Hold
993
0.01% 250
2020
Q3
$164K Sell
993
-997
-50% -$153K 0.01% 229
2020
Q2
$273K Buy
1,990
+989
+99% +$129K 0.03% 167
2020
Q1
$118K Sell
1,001
-1,521
-60% -$200K 0.02% 238
2019
Q4
$334K Buy
2,522
+21
+0.8% +$2.61K 0.04% 161
2019
Q3
$312K Buy
+2,501
New +$302K 0.04% 195

Other funds holding ZTS

Evoke Wealth's ZTS Position: Q1 2026 in Review

Evoke Wealth increased its Zoetis (ZTS) stake by 18% in Q1 2026, buying an estimated $45.9K and bringing the position to 2,442 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #552.

Evoke Wealth first reported a position in ZTS in Q3 2019 and has held it in 24 quarters since. The position peaked at $772K in Q4 2021. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Evoke Wealth held 2,442 shares of Zoetis worth $289K as of Q1 2026.
  • Evoke Wealth bought 371 Zoetis shares in Q1 2026, an estimated $45.9K.
  • Zoetis made up 0.01% of Evoke Wealth's portfolio in Q1 2026, its #552 holding.
  • Evoke Wealth first reported a position in Zoetis in Q3 2019 and has held it in 24 quarters since.
  • Evoke Wealth's Zoetis position peaked at $772K in Q4 2021.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.